Carbohydrate antigens

Current Opinion in Organ Transplantation

Volumn 17, Issue 2, 2012, Pages 174-179

  Miyagawa, Shuji ^a   Ueno, Takehisa ^a   Nagashima, Hiroshi ^b   Takama, Yuichi ^a   Fukuzawa, Masahiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJI UNIVERSITY   (Japan)

Author keywords

carbohydrate antigens; nongal; xenotransplantation

Indexed keywords

ANTIGEN; CARBOHYDRATE ANTIGEN; GLOBOTRIAOSYLCERAMIDE; GLYCOSYLTRANSFERASE; HANGANUTZIU DEICHER ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; BLOOD GROUP; CYTOTOXICITY; ENDOGENOUS RETROVIRUS; GLYCOSYLATION; NATURAL KILLER CELL; NONHUMAN; REVIEW; TRANSGENIC PIG; VIRUS INFECTIVITY; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS; CARBOHYDRATES; HUMANS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84858797771     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283508189     Document Type: Review

References (54)

1. Galili U, Clark MR, Shohet SB, et al. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1,3Gal epitope in primates. Proc Natl Acad Sci USA 1987; 84:1369-1373. (Pubitemid 17027355)
2. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20:251-255. (Pubitemid 34205417)
3. Takahagi Y, Fujimura T, Miyagawa S, et al. Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev 2005; 71:331-338. (Pubitemid 40770387)
4. Hauschild J, Petersen B, Santiago Y, et al. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA 2011; 108:12013-12017.
5. Keusch JJ, Manzella SM, Nyame KA, et al. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000; 275:25308-25314.
6. Taylor SG, McKenzie IF, Sandrin IF. Characterization of the rat alpha(1,3)-galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology 2003; 13:327-337. (Pubitemid 36592320)
7. Milland J, Christiansen D, Lazarus BD, et al. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 2006; 176:2448-2454. (Pubitemid 43201695)
8. Sandrin IF, Christiansen D, Milland J. The impact of the a1,3-galactosyltransferase gene knockout pig on xenotransplantation. Curr Opin Organ Transplant 2007; 2:154-157. (Pubitemid 46941250)
9. Diswell M, Angstom J, Schuurman HJ, et al. Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine. Transplantation 2007; 84:1348-1356.
10. Diswall M, Angström J, Karlsson H, et al. Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010; 17:48-60.
11. Diswall M, Gustafsson A, Holgersson J, et al. Antigen-binding specificity of anti(Gal reagents determined by solid-phase glycolipid-binding assays. A complete lack of (Gal glycolipid reactivity in (1,3GalT-KO pig small intestine. Xenotransplantation 2011; 18:28-39.
12. Kiernan K, Harnden I, Gunthart M, et al. The anti-nonGal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 2008; 8:1829-1839.
13. Yung GP, Schneider MK, Seebach JD. Immune responses to alpha1,3 galactosyltransferase knockout pigs. Curr Opin Organ Transplant 2009; 14:154-160.
14. Gusstafsson A, Ayares DL, Cooper DKC, et al. Carbohydrate phenotyping of endothelial cell glycoproteins from alpha1,3galactosyl-transferase geneknockout and wild type pigs. Xenotransplantation 2005; 12:375.
15. Milland J, Christiansen D, Sandrin MS. Alpha1,3-galactosyltransferase knockout pigs are available for xenotransplantation: are glycosyltransferases still relevant? Immunol Cell Biol 2005; 3:687-693. (Pubitemid 43083101)
16. Miyagawa S, Takeishi S, Yamamoto A, et al. Survey of glycoantigens in cells from alpha1-3galactosyltransferase knockout pig using a lectin microarray. Xenotransplantation 2010; 17:61-70.
17. Oriol R, Ye Y, Koren E, et al. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56:1433-1442. (Pubitemid 24018801)
18. Bouhours D, Liaigre J, Naulet J, et al. A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. Glycobiology 2000; 10:857-864.
19. Hallberg EC, Holgersson J, Samuelsson BE. Glycosphingolipid expression in pig aorta: identification of possible target antigens for human natural antibodies. Glycobiology 1998; 8:637-649. (Pubitemid 28331440)
20. Kim YG, Gil GC, Harvey DJ, et al. Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney. Proteomics 2008; 8:2596-2610. (Pubitemid 351988566)
21. Blixt O, Kumagai-Braesch M, Tibell A, et al. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. American J Transplant 2009; 9:83-90.
22. Breimer ME. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation. 2011; 18:215-228.
23. Zhu A. Binding of human natural antibodies to nonalphaGal xenoantigens on porcine erythrocytes. Transplantation 2000; 69:2422-2428. (Pubitemid 30409015)
24. Buhler L, Xu Y, Li W, et al. An investigation of the specificity of induced antipig antibodies in baboons. Xenotransplantation 2003; 10:88-93. (Pubitemid 36908962)
25. Komoda H, Miyagawa S, Kubo T, et al. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004; 11:237-246. (Pubitemid 38623060)
26. Byrne GW, Stalboerger PG, Davila E, et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008; 15:268-276.
27. Montiel MD, Krzewinski-Recchi MA, Delannoy P, et al. Molecular cloning, gene organization and expression of the human UDP-GalNAc: Neu5Acalpha2-3Galbeta- R beta1,4-N-acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sda/Cad antigen: evidence for an unusual extended cytoplasmic domain. Biochem J 2003; 373:369-379. (Pubitemid 36897840)
28. Byrne GW, Stalboerger PG, Du Z, et al. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 2011; 91:287-292.
29. Irie A, Koyama S, Kozutsumi Y, et al. The molecular basis for the absence of Nglycolylneuraminic acid in humans. J Biol Chem 1998; 273:15866-15871. (Pubitemid 28298210)
30. Chou HH, Takematsu H, Diaz S, et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 1998; 95:11751-11756.
31. Maria Hedlund, Pam Tangvoranuntakul, Hiromu Takematsu, et al. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol 2007; 27:4340-4346. (Pubitemid 46906558)
32. Miwa Y, Kobayashi T, Nagasaka T, et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004; 11:247-253. (Pubitemid 38623061)
33. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9:376-381. (Pubitemid 36358933)
34. Magnusson S, Mansson JE, Strokan V, et al. Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens. Xenotransplantation 2003; 10:432-445. (Pubitemid 37129888)
35. Saethre M, Baumann BC, Fung M, et al. Characterization of natural human antinon-Gal antibodies and their effect on activation of porcine Gal-deficient endothelial cells. Transplantation 2007; 84:244-250. (Pubitemid 47205759)
36. Basnet NB, Ide K, Tahara H, et al. Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 2010; 17:440-448.
37. Padler-Karavani V, Varki A. Uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci USA 2010; 107 (Supplement-2):8939-8946.
38. Ajit Varki. Potential impact of the nonhuman sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011; 18:1-5.
39. Song KH, Kang YJ, Jin UH, et al. Cloning and functional characterization of pig CMP-N-acetylneuraminic acid hydroxylase for the synthesis of N-glycolylneuraminic acid as the xenoantigenic determinant in pig-human xenotransplantation. Biochem J 2010; 427:179-188.
40. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995; 1:1261-1267.
41. Tanemura M, Miyagawa S, Koyota S, et al. Reduction of the major swine xenoantigen, the alpha-galactosyl epitope by transfection of the alpha2,3-sialyltransferase gene. J Biol Chem 1998; 273:16421-16425. (Pubitemid 28311423)
42. Miyagawa S, Murakami H, Takahagi T, et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001; 276:39310-39319.
43. Yazaki S, Iwamoto M, Onishi A, et al. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor. Xenotransplantation 2009; 16:511-521.
44. Miyagawa S, Nakai R, Yamada M, et al. Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen. J Biochem 1999; 126:1067-1073. (Pubitemid 30014453)
45. Artrip JH, Kwiatkowski P, Michler RE, et al. Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)- galactosyltransferase and reduced by alpha (1,2)-fucosyltransferase. J Biol Chem 1999; 274:10717-10722.
46. Horvath-Arcidiacono JA, Porter CM, Bloom ET. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 2006; 13:318-327. (Pubitemid 43884466)
47. Baumann BC, Forte P, Hawley RJ, et al. Lack of galactose-alpha-1,3- galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 2004; 172:6460-6467. (Pubitemid 38621256)
48. Baumann BC, Schneider MK, Lilienfeld BG, et al. Endothelial cells derived from pigs lacking Gal alpha (1,3)Gal: no reduction of human leukocyte adhesion and natural killer cell cytotoxicity. Transplantation 2005; 79:1067-1072. (Pubitemid 40663999)
49. Christiansen D, Mouhtouris E, Milland J, et al. Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161). Xenotransplantation 2006; 13: 440-446. (Pubitemid 44265713)
50. Jin R, Greenwald A, Peterson MD, et al. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL. J Immunol 2006; 177:1289-1295. (Pubitemid 44036635)
51. Scobie L, Takeuchi Y. Porcine endogenous retrovirus and other viruses in xenotransplantation. Curr Opin Organ Transplant 2009; 14:175-179.
52. Hazama K, Miyagawa S, Miyazawa T, et al. The significance of N-linked glycosylation in pig endogenous retrovirus infectivity. Biochem Biophys Res Commun 2003; 310:327-333. (Pubitemid 37163667)
53. Miyagawa S, Nakatsu S, Hazama K, et al. A novel strategy for preventing PERV transmission to human cells by remodeling the viral envelope glycoprotein. Xenotransplantation 2006; 13:258-263. (Pubitemid 43824216)
54. Yamamoto A, Nakatsu S, Kondo A, et al. A newly cloned pig dolichylphosphate mannosyl-transferase for preventing the transmission of porcine endogenous retrovirus to human cells. Transpl Int 2010; 23:424-431.